These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9001344)

  • 41. Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan.
    Chu JS; Huang CS; Chang KJ
    Cancer Lett; 1998 Sep; 131(2):145-52. PubMed ID: 9851246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological behavior of mucoepidermoid carcinoma of the esophagus.
    Hagiwara N; Tajiri T; Tajiri T; Miyashita M; Sasajima K; Makino H; Matsutani T; Tsuchiya Y; Takubo K; Yamashita K
    J Nippon Med Sch; 2003 Oct; 70(5):401-7. PubMed ID: 14578940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas.
    Tsai ST; Jin YT
    J Oral Pathol Med; 1995 Aug; 24(7):313-5. PubMed ID: 7473268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical studies of vascular volume and proliferative activity in squamous cell carcinoma of the esophagus.
    Koide N; Yamanda T; Iida F; Usuda N; Nagata T
    Surg Today; 1997; 27(2):99-106. PubMed ID: 9017984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of proliferating cell nuclear antigen expression and prognosis in patients with renal cell carcinoma with pulmonary metastases.
    Gotoh A; Hanioka K; Shirakawa T; Wada Y; Gohji K; Okada H; Arakawa S; Kamidono S
    Int J Urol; 1998 May; 5(3):214-8. PubMed ID: 9624550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
    Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
    World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma.
    Boran C; Yildiz L; Kandemir B; Karagoz F; Baris S; Aydin O
    Neoplasma; 2003; 50(2):139-43. PubMed ID: 12740649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
    Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
    Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
    Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
    Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Correlation between prognosis and cell proliferation, apoptosis in squamous cell carcinoma of tongue].
    Yang YP; Qing HY; Cao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):31-4. PubMed ID: 12760773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Correlation of GST-pi and PCNA expression to prognosis of advanced maxillary sinus squamous cell carcinoma].
    Guo GF; Xie RH; Yang AK; Chen ZH; Wu QL; Liu WW; Ou SM; Xia LP; Chen MY; Zhang JX
    Ai Zheng; 2005 Oct; 24(10):1267-71. PubMed ID: 16219146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Highly aggressive behavior and poor prognosis of small-cell carcinoma in the alimentary tract: flow-cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen.
    Kimura H; Konishi K; Maeda K; Yabushita K; Tsuji M; Miwa A
    Dig Surg; 1999; 16(2):152-7. PubMed ID: 10207243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
    Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system.
    Zhu SC; Li R; Wang YX; Feng W; Li J; Qiu R
    World J Gastroenterol; 2005 Jul; 11(25):3823-9. PubMed ID: 15991276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic significance of cell cycle markers in esophageal cancer after neoadjuvant chemotherapy.
    Yasunaga M; Tabira Y; Kondo K; Okuma T; Kitamura N
    Dis Esophagus; 1999; 12(2):120-7. PubMed ID: 10466044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?
    Situ D; Wang J; Lin P; Long H; Zhang L; Rong T; Ma G
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):45-51. PubMed ID: 23490249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The proliferative activity of laryngeal carcinoma and its relationship to histological malignancy and prognosis].
    Zhang Q; Li Y; Liu J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(5):305-7. PubMed ID: 8762515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
    Saeki H; Tsutsumi S; Tajiri H; Yukaya T; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakanishi R; Nakashima Y; Sugiyama M; Ohgaki K; Sonoda H; Oki E; Maehara Y
    Ann Surg; 2017 Mar; 265(3):527-533. PubMed ID: 28169928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
    Visakorpi T
    J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.